№ files_lp_4_process_3_073637
File format: docx Character count: 1743 File size: 36 KB
Supplemental figure legends and experimental results from preclinical and clinical studies detailing antitumor effects and MET biomarker analyses across multiple cancer types.
Year: 2026
Region / City: International
Theme: Oncology, Targeted Therapy
Document Type: Supplemental Figure Legends
Institution / Organization: Clinical Research Team
Authors: Not specified
Target Population: Patients with MET-positive gastric, hepatocellular, renal, and non-small cell lung cancers
Study Period: Preclinical and clinical exploratory analyses
Data Collection Date: Not specified
Drug Dosage: Emibetuzumab 20 mg/kg qw, DC101 20 mg/kg 2qw intraperitoneally
Endpoints: Progression-free survival, tumor response, biomarker expression
Cancer Types: Gastric cancer, hepatocellular carcinoma, renal cell carcinoma, non-small cell lung cancer
Methodology: Preclinical xenograft models, biomarker stratification, exploratory cut-off analysis
Supplement Figures: Figures 1–3
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.